Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Preventing enduring behavioural problems in young children through early psychological intervention (Healthy Start, Happy Start): study protocol for a randomized controlled trial.

Ramchandani PG, O'Farrelly C, Babalis D, Bakermans-Kranenburg MJ, Byford S, Grimas ESR, Iles JE, van IJzendoorn MH, McGinley J, Phillips CM, Stein A, Warwick J, Watt HC, Scott S.

Trials. 2017 Nov 15;18(1):543. doi: 10.1186/s13063-017-2293-9.

2.

Contract and ownership type of general practices and patient experience in England: multilevel analysis of a national cross-sectional survey.

Cowling TE, Laverty AA, Harris MJ, Watt HC, Greaves F, Majeed A.

J R Soc Med. 2017 Nov;110(11):440-451. doi: 10.1177/0141076817738499. Epub 2017 Nov 2.

3.

The Association Between Chronic Pain and Cardiac Disease: A Cross-sectional Population Study.

Fayaz A, Watt HC, Langford RM, Donaldson LJ.

Clin J Pain. 2016 Dec;32(12):1062-1068.

4.

A Metabolic Study of Huntington's Disease.

Nambron R, Silajdžić E, Kalliolia E, Ottolenghi C, Hindmarsh P, Hill NR, Costelloe SJ, Martin NG, Positano V, Watt HC, Frost C, Björkqvist M, Warner TT.

PLoS One. 2016 Jan 8;11(1):e0146480. doi: 10.1371/journal.pone.0146480. eCollection 2016.

5.

A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.

Kalliolia E, Silajdžić E, Nambron R, Costelloe SJ, Martin NG, Hill NR, Frost C, Watt HC, Hindmarsh P, Björkqvist M, Warner TT.

PLoS One. 2015 Oct 2;10(10):e0138848. doi: 10.1371/journal.pone.0138848. eCollection 2015.

6.

Impact of a COPD discharge care bundle on readmissions following admission with acute exacerbation: interrupted time series analysis.

Laverty AA, Elkin SL, Watt HC, Millett C, Restrick LJ, Williams S, Bell D, Hopkinson NS.

PLoS One. 2015 Feb 13;10(2):e0116187. doi: 10.1371/journal.pone.0116187. eCollection 2015.

7.

Use and abuse of statistics in tobacco industry-funded research on standardised packaging.

Laverty AA, Diethelm P, Hopkinson NS, Watt HC, McKee M.

Tob Control. 2015 Sep;24(5):422-4. doi: 10.1136/tobaccocontrol-2014-052051. Epub 2015 Feb 3.

8.

Access to general practice and visits to accident and emergency departments in England: cross-sectional analysis of a national patient survey.

Cowling TE, Harris MJ, Watt HC, Gibbons DC, Majeed A.

Br J Gen Pract. 2014 Jul;64(624):e434-9. doi: 10.3399/bjgp14X680533.

9.

Standardised packaging and tobacco-industry-funded research.

Laverty AA, Watt HC, Arnott D, Hopkinson NS.

Lancet. 2014 Apr 19;383(9926):1384. doi: 10.1016/S0140-6736(14)60499-2. Epub 2014 Apr 9. No abstract available.

PMID:
24726722
10.

Influence of area and individual lifecourse deprivation on health behaviours: findings from the British Women's Heart and Health Study.

Amuzu A, Carson C, Watt HC, Lawlor DA, Ebrahim S.

Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):169-73. doi: 10.1097/HJR.0b013e328325d64d.

PMID:
19242356
11.

Influence of life course socioeconomic position on older women's health behaviors: findings from the British Women's Heart and Health Study.

Watt HC, Carson C, Lawlor DA, Patel R, Ebrahim S.

Am J Public Health. 2009 Feb;99(2):320-7. doi: 10.2105/AJPH.2007.129288. Epub 2008 Dec 4.

12.

Life-course socio-economic position, area deprivation and Type 2 diabetes: findings from the British Women's Heart and Health Study.

Andersen AF, Carson C, Watt HC, Lawlor DA, Avlund K, Ebrahim S.

Diabet Med. 2008 Dec;25(12):1462-8. doi: 10.1111/j.1464-5491.2008.02594.x.

PMID:
19046246
13.

Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia.

Barnes TR, Leeson VC, Mutsatsa SH, Watt HC, Hutton SB, Joyce EM.

Br J Psychiatry. 2008 Sep;193(3):203-9. doi: 10.1192/bjp.bp.108.049718.

14.

Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study.

Williams DR, Watt HC, Lees AJ.

J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):468-73.

15.

Comorbid substance use and age at onset of schizophrenia.

Barnes TR, Mutsatsa SH, Hutton SB, Watt HC, Joyce EM.

Br J Psychiatry. 2006 Mar;188:237-42.

PMID:
16507965
16.

A volumetric magnetic resonance imaging study of the amygdala in frontotemporal lobar degeneration and Alzheimer's disease.

Whitwell JL, Sampson EL, Watt HC, Harvey RJ, Rossor MN, Fox NC.

Dement Geriatr Cogn Disord. 2005;20(4):238-44. Epub 2005 Aug 5.

17.

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ.

Brain. 2005 Jun;128(Pt 6):1247-58. Epub 2005 Mar 23.

PMID:
15788542
18.

A standardised method for measuring magnetisation transfer ratio on MR imagers from different manufacturers--the EuroMT sequence.

Barker GJ, Schreiber WG, Gass A, Ranjeva JP, Campi A, van Waesberghe JH, Franconi JM, Watt HC, Tofts PS.

MAGMA. 2005 May;18(2):76-80. Epub 2005 Mar 22.

PMID:
15785944
19.

Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study.

Chan D, Janssen JC, Whitwell JL, Watt HC, Jenkins R, Frost C, Rossor MN, Fox NC.

Lancet. 2003 Oct 4;362(9390):1121-2.

PMID:
14550701
20.

Using Down syndrome serum screening results to predict low birthweight.

Huang T, Alberman E, Watt HC, Wald NJ.

Prenat Diagn. 2003 May;23(5):420-6.

PMID:
12749041
21.

The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study.

Dehmeshki J, Chard DT, Leary SM, Watt HC, Silver NC, Tofts PS, Thompson AJ, Miller DH.

J Neurol. 2003 Jan;250(1):67-74.

PMID:
12527995
22.

Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease.

Petzold A, Jenkins R, Watt HC, Green AJ, Thompson EJ, Keir G, Fox NC, Rossor MN.

Neurosci Lett. 2003 Jan 23;336(3):167-70.

PMID:
12505619
23.

The underlying risk of death after myocardial infarction in the absence of treatment.

Law MR, Watt HC, Wald NJ.

Arch Intern Med. 2002 Nov 25;162(21):2405-10.

24.

Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding.

Tabor A, Watt HC, Wald NJ.

Obstet Gynecol. 2002 Apr;99(4):663-70.

PMID:
12039131
25.

Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging.

Whitwell JL, Crum WR, Watt HC, Fox NC.

AJNR Am J Neuroradiol. 2001 Sep;22(8):1483-9.

26.

The target plot: a new way of displaying the performance of a screening test.

Wald NJ, Watt HC.

J Med Screen. 1999;6(4):195-9.

PMID:
10693065
27.

Adding free to total prostate-specific antigen levels in trials of prostate cancer screening.

Wald NJ, Watt HC, George L, Knekt P, Helzlsouer KJ, Tuomilehto J.

Br J Cancer. 2000 Feb;82(3):731-6.

28.

Inhibin-A regression.

Watt HC, Wald NJ, Huttly WJ.

Prenat Diagn. 1999 Sep;19(9):893-4. No abstract available.

PMID:
10521856
29.
30.

SP1 in pregnancies with Down syndrome in the first trimester of pregnancy. International Prenatal Screening Research Group.

Wald NJ, Watt HC, Norgaard-Pedersen B, Christiansen M.

Prenat Diagn. 1999 Jun;19(6):517-20.

PMID:
10416965
31.

Fetal loss in Down syndrome pregnancies.

Morris JK, Wald NJ, Watt HC.

Prenat Diagn. 1999 Feb;19(2):142-5.

PMID:
10215072
32.

Serum triglyceride: a possible risk factor for ruptured abdominal aortic aneurysm.

Watt HC, Law MR, Wald NJ, Craig WY, Ledue TB, Haddow JE.

Int J Epidemiol. 1998 Dec;27(6):949-52.

PMID:
10024187
33.

The pattern of maternal serum inhibin-A concentrations in the second trimester of pregnancy.

Watt HC, Wald NJ, Huttly WJ.

Prenat Diagn. 1998 Aug;18(8):846-8.

PMID:
9742576
35.

Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.

Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM.

Arch Intern Med. 1998 Apr 27;158(8):862-7.

PMID:
9570171
36.

Screening for Down syndrome at 14 weeks of pregnancy.

Wald NJ, Watt HC, Haddow JE, Knight GJ.

Prenat Diagn. 1998 Mar;18(3):291-3.

PMID:
9556047
39.

Reliability of statistics on Down's syndrome notifications.

Huang T, Watt HC, Wald NJ, Morris JK, Mutton D, Alberman E.

J Med Screen. 1997;4(2):95-7.

PMID:
9275267
40.
41.

Maternal serum inhibin-A levels in twin pregnancies: implications for screening for Down's syndrome.

Watt HC, Wald NJ, George L.

Prenat Diagn. 1996 Oct;16(10):927-9.

PMID:
8938062
42.
43.
44.

Effect of allowing for ethnic group in prenatal screening for Down's syndrome.

Watt HC, Wald NJ, Smith D, Kennard A, Densem J.

Prenat Diagn. 1996 Aug;16(8):691-8.

PMID:
8878277
45.

Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer.

Parkes C, Wald NJ, Murphy P, George L, Watt HC, Kirby R, Knekt P, Helzlsouer KJ, Tuomilehto J.

BMJ. 1995 Nov 18;311(7016):1340-3.

46.

Value of maternal serum unconjugated oestriol measurement in prenatal screening for Down's syndrome.

Wald NJ, Kennard A, Watt HC, Smith D.

Prenat Diagn. 1994 Aug;14(8):699-706.

PMID:
7527536
47.

Choice of serum markers in antenatal screening for Down's syndrome.

Wald NJ, Watt HC.

J Med Screen. 1994 Apr;1(2):117-20. No abstract available.

PMID:
8790499
48.

Apolipoproteins and ischaemic heart disease: implications for screening.

Wald NJ, Law M, Watt HC, Wu T, Bailey A, Johnson AM, Craig WY, Ledue TB, Haddow JE.

Lancet. 1994 Jan 8;343(8889):75-9.

PMID:
7903777

Supplemental Content

Support Center